Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Telo Genomics Corp (TDSGF)

Telo Genomics Corp (TDSGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TDSGF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0829 +48.61%
on 03/28/24
0.1609 -23.43%
on 04/22/24
+0.0406 (+49.15%)
since 03/26/24
3-Month
0.0761 +61.89%
on 03/11/24
0.1609 -23.43%
on 04/22/24
+0.0009 (+0.74%)
since 01/25/24
52-Week
0.0761 +61.89%
on 03/11/24
0.2400 -48.67%
on 06/13/23
-0.0864 (-41.22%)
since 04/25/23

Most Recent Stories

More News
Telo Genomics Receives Accreditation from College of American Pathologists

Toronto, Ontario--(Newsfile Corp. - April 10, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Telo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial

Toronto, Ontario--(Newsfile Corp. - April 2, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients

Toronto, Ontario--(Newsfile Corp. - February 13, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that it has received the first patient sample for...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
BMY : 44.85 (+0.34%)
TMO : 573.60 (+0.33%)
NTRA : 91.66 (+0.42%)
NEO : 14.14 (+2.09%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
BMY : 44.85 (+0.34%)
TMO : 573.60 (+0.33%)
NTRA : 91.66 (+0.42%)
NEO : 14.14 (+2.09%)
Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US

Toronto, Ontario--(Newsfile Corp. - January 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that it has engaged Trusted Health Advisors (THA),...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Telo Genomics Gears up for American Society of Hematology Conference

Toronto, Ontario--(Newsfile Corp. - December 6, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company" or "Telo"), an emerging molecular testing platform provider leveraging...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Telo Genomics Launches Physician Experience Program in the United States

SMART Observational Study a Critical Step Toward Full Platform AvailabilityToronto, Ontario--(Newsfile Corp. - November 16, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company"...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
Telo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists

An Important Accreditation Milestone Achieved Towards Full Commercial AvailabilityToronto, Ontario--(Newsfile Corp. - November 7, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A), (the...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)
American Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting

ASH is the world leader in supporting clinical and scientific hematology researchToronto, Ontario--(Newsfile Corp. - November 1, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or...

TDSGF : 0.1232 (-14.03%)
TELO.VN : 0.170 (-5.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.1344
2nd Resistance Point 0.1321
1st Resistance Point 0.1277
Last Price 0.1232
1st Support Level 0.1210
2nd Support Level 0.1187
3rd Support Level 0.1143

See More

52-Week High 0.2400
Fibonacci 61.8% 0.1774
Fibonacci 50% 0.1581
Fibonacci 38.2% 0.1387
Last Price 0.1232
52-Week Low 0.0761

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar